Does AK-2123 (Senazole) have sensitizing effects on radiation, cisplatin and hyperthermia under aerobic conditions in vitro?

Anticancer Res. 1998 Sep-Oct;18(5A):3463-7.

Abstract

We investigated the sensitizing effects of AK-2123 (Senazole) on the interaction of radiation, cisplatin and hyperthermia under aerobic conditions in the rat yolk sac cell line NMT-1R in vitro. The effects were assessed by clonogenic assay. A cytotoxic effect of AK-2123 after 24 hours exposure was observed as a function of the dose. For NMT-1R cells, the ID70 of AK-2123 was 400 micrograms/ml for 24 hours exposure, which was employed for subsequent combined treatments. Although a statistically significant increase in the G1 cell fraction was observed after AK-2123 treatment with a dose of ID70 (p = 0.02) no enhancing effect of AK-2123 on radiation, cisplatin or heat response curves was detected under aerobic conditions in vitro.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cell Cycle / radiation effects
  • Cisplatin / pharmacology*
  • Dose-Response Relationship, Drug
  • Dose-Response Relationship, Radiation
  • Hyperthermia, Induced*
  • Radiation-Sensitizing Agents / pharmacology*
  • Rats
  • Triazoles / pharmacology*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / radiation effects

Substances

  • Antineoplastic Agents
  • Radiation-Sensitizing Agents
  • Triazoles
  • AK 2123
  • Cisplatin